Definity
FDA Approves First Drug-Eluting Stent to Treat Peripheral Arterial Disease »
"The U.S. Food and Drug Administration approved the Zilver PTX Drug-Eluting Peripheral Stent (Zilver PTX Stent), the first drug-eluting stent indicated to re-open a particular artery in the thigh (femoropopliteal artery) when narrowed or blocked a"...
Read the FDA Approves First Drug-Eluting Stent to Treat Peripheral Arterial Disease article »
Definity
OVERDOSE
The clinical consequences of overdosing with activated DEFINITY® are not known. Treatment of an overdose should be directed toward the support of all vital functions and prompt institution of symptomatic therapy [see CONTRAINDICATIONS and WARNINGS AND PRECAUTIONS].
CONTRAINDICATIONS
Do not administer DEFINITY® to patients with known or suspected:
- Right-to-left, bi-directional, or transient right-to-left cardiac shunts,
- Hypersensitivity to perflutren [see WARNINGS AND PRECAUTIONS].
Do not administer DEFINITY® by intra-arterial injection.
Last reviewed on RxList: 11/4/2011
This monograph has been modified to include the generic and brand name in many instances.
Additional Definity Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Heart Health
Get the latest treatment options.
Updated & New
